Alpha MSH in Ocular Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 60 - Any |
| Updated: | 3/1/2019 |
| Start Date: | March 6, 2018 |
| End Date: | August 1, 2020 |
| Contact: | Latoya Greene |
| Email: | latoya.greene@duke.edu |
| Phone: | 919-684-9072 |
The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease
The purpose of this study is gain a better understanding of a molecule called alpha
melanocyte stimulating hormone (alpha MSH) and its potential role in your retinal disease.
Alpha MSH has been shown to have an important role in the regulation of ocular immunity in
animal models of inflammatory retinal diseases and retinal dystrophies, and there may be a
protective effect of alpha MSH. By studying the levels of alpha MSH in your eye we may better
understand its role in advanced dry macular degeneration. By studying the levels of this
molecule we hope to better understand if it may be a good target for future treatment.
melanocyte stimulating hormone (alpha MSH) and its potential role in your retinal disease.
Alpha MSH has been shown to have an important role in the regulation of ocular immunity in
animal models of inflammatory retinal diseases and retinal dystrophies, and there may be a
protective effect of alpha MSH. By studying the levels of alpha MSH in your eye we may better
understand its role in advanced dry macular degeneration. By studying the levels of this
molecule we hope to better understand if it may be a good target for future treatment.
A small amount (0.1 mL) of aqueous humor would be removed from the study eye in the clinic
setting. This sample will be processed and then sent off for measurement of alpha MSH levels.
setting. This sample will be processed and then sent off for measurement of alpha MSH levels.
Inclusion Criteria:
- 60 years or older
- diagnosis of advanced dry macular degeneration with foveal geographic atrophy
- limited vision or blindness (20/100 or worse) in that eye
- pseudophakia (prior cataract surgery in that eye)
Exclusion Criteria:
We found this trial at
1
site
Durham, North Carolina 27710
Principal Investigator: Sharon Fekrat, MD
Phone: 919-684-9072
Click here to add this to my saved trials
